306 related articles for article (PubMed ID: 37098777)
1. IL-23/IL-17 immune axis mediates the imiquimod-induced psoriatic inflammation by activating ACT1/TRAF6/TAK1/NF-κB pathway in macrophages and keratinocytes.
Chen WC; Wen CH; Wang M; Xiao ZD; Zhang ZZ; Wu CL; Wu R
Kaohsiung J Med Sci; 2023 Aug; 39(8):789-800. PubMed ID: 37098777
[TBL] [Abstract][Full Text] [Related]
2. Gain-of-Function Mutation of Card14 Leads to Spontaneous Psoriasis-like Skin Inflammation through Enhanced Keratinocyte Response to IL-17A.
Wang M; Zhang S; Zheng G; Huang J; Songyang Z; Zhao X; Lin X
Immunity; 2018 Jul; 49(1):66-79.e5. PubMed ID: 29980436
[TBL] [Abstract][Full Text] [Related]
3.
Yang BY; Cheng YG; Liu Y; Liu Y; Tan JY; Guan W; Guo S; Kuang HX
Molecules; 2019 Jun; 24(11):. PubMed ID: 31181689
[TBL] [Abstract][Full Text] [Related]
4. Khasianine ameliorates psoriasis-like skin inflammation and represses TNF-α/NF-κB axis mediated transactivation of IL-17A and IL-33 in keratinocytes.
Yang Y; Zhang Y; Chen X; Su Z; Deng Y; Zhao Q
J Ethnopharmacol; 2022 Jun; 292():115124. PubMed ID: 35183690
[TBL] [Abstract][Full Text] [Related]
5. Serine deficiency exacerbates psoriatic skin inflammation by regulating S-adenosyl methionine-dependent DNA methylation and NF-κB signalling activation in keratinocytes.
Meng Q; Liu Y; Yao L; Ma Z; Guo L; Hu T; Luo Y; Chen J; Dang E; Li Z
J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):145-156. PubMed ID: 37669859
[TBL] [Abstract][Full Text] [Related]
6. Eupatilin inhibits keratinocyte proliferation and ameliorates imiquimod-induced psoriasis-like skin lesions in mice via the p38 MAPK/NF-κB signaling pathway.
Bai D; Cheng X; Li Q; Zhang B; Zhang Y; Lu F; Sun T; Hao J
Immunopharmacol Immunotoxicol; 2023 Apr; 45(2):133-139. PubMed ID: 36305632
[TBL] [Abstract][Full Text] [Related]
7. Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice.
Gao J; Chen F; Fang H; Mi J; Qi Q; Yang M
Biol Res; 2020 Oct; 53(1):48. PubMed ID: 33081840
[TBL] [Abstract][Full Text] [Related]
8. Allicin ameliorates imiquimod-induced psoriasis-like skin inflammation via disturbing the interaction of keratinocytes with IL-17A.
Zhang L; Ma X; Shi R; Zhang L; Zhao R; Duan R; Qin Y; Gao S; Li X; Duan J; Li J
Br J Pharmacol; 2023 Mar; 180(5):628-646. PubMed ID: 36355777
[TBL] [Abstract][Full Text] [Related]
9. PDRN, a Bioactive Natural Compound, Ameliorates Imiquimod-Induced Psoriasis through NF-κB Pathway Inhibition and Wnt/β-Catenin Signaling Modulation.
Irrera N; Bitto A; Vaccaro M; Mannino F; Squadrito V; Pallio G; Arcoraci V; Minutoli L; Ieni A; Lentini M; Altavilla D; Squadrito F
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059361
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA, a component of the self-made Xiao-Yin decoction, ameliorates psoriasis by inhibiting IL-17/IL-23 and PTGS2/NF-κB/AP-1 pathways.
Fu L; Li M; Wang P; Chen L; Huang J; Zhang H
Skin Res Technol; 2024 Feb; 30(2):e13577. PubMed ID: 38284293
[TBL] [Abstract][Full Text] [Related]
11. FXYD3 enhances IL-17A signaling to promote psoriasis by competitively binding TRAF3 in keratinocytes.
Yang W; He R; Qu H; Lian W; Xue Y; Wang T; Lin W; Zhu P; Xia M; Lai L; Wang Q
Cell Mol Immunol; 2023 Mar; 20(3):292-304. PubMed ID: 36693922
[TBL] [Abstract][Full Text] [Related]
12. The STING antagonist H-151 ameliorates psoriasis via suppression of STING/NF-κB-mediated inflammation.
Pan Y; You Y; Sun L; Sui Q; Liu L; Yuan H; Chen C; Liu J; Wen X; Dai L; Sun H
Br J Pharmacol; 2021 Dec; 178(24):4907-4922. PubMed ID: 34460100
[TBL] [Abstract][Full Text] [Related]
13. Cang-ai volatile oil ameliorates imiquimod-induced psoriatic skin lesions by suppressing the ILC3s.
Lin Y; Yin X; Ma S; Xue Y; Hu C; Xie Y; Zeng Y; Zhao X; Du C; Sun Y; Qu L; Xiong L; Huang F
J Ethnopharmacol; 2024 May; 326():117867. PubMed ID: 38342155
[TBL] [Abstract][Full Text] [Related]
14.
Fujii K; Yamamoto Y; Mizutani Y; Saito K; Seishima M
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752186
[No Abstract] [Full Text] [Related]
15. Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation.
Wang Z; Zhou H; Zheng H; Zhou X; Shen G; Teng X; Liu X; Zhang J; Wei X; Hu Z; Zeng F; Hu Y; Hu J; Wang X; Chen S; Cheng J; Zhang C; Gui Y; Zou S; Hao Y; Zhao Q; Wu W; Zhou Y; Cui K; Huang N; Wei Y; Li W; Li J
Autophagy; 2021 Feb; 17(2):529-552. PubMed ID: 32019420
[TBL] [Abstract][Full Text] [Related]
16. Epithelial TRAF6 drives IL-17-mediated psoriatic inflammation.
Matsumoto R; Dainichi T; Tsuchiya S; Nomura T; Kitoh A; Hayden MS; Ishii KJ; Tanaka M; Honda T; Egawa G; Otsuka A; Nakajima S; Sakurai K; Nakano Y; Kobayashi T; Sugimoto Y; Kabashima K
JCI Insight; 2018 Aug; 3(15):. PubMed ID: 30089718
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rg1 abolish imiquimod-induced psoriasis-like dermatitis in BALB/c mice via downregulating NF-κB signaling pathway.
Shi Q; He Q; Chen W; Long J; Zhang B
J Food Biochem; 2019 Nov; 43(11):e13032. PubMed ID: 31502279
[TBL] [Abstract][Full Text] [Related]
18. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
[TBL] [Abstract][Full Text] [Related]
19. Endogenous n-3 polyunsaturated fatty acids protect against imiquimod-induced psoriasis-like inflammation via the IL-17/IL-23 axis.
Qin S; Wen J; Bai XC; Chen TY; Zheng RC; Zhou GB; Ma J; Feng JY; Zhong BL; Li YM
Mol Med Rep; 2014 Jun; 9(6):2097-104. PubMed ID: 24718773
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of punicalagin attenuates imiquimod-induced psoriasis by reducing ROS generation and inflammation via MAPK/ERK and NF-κB signaling pathways.
Wang Y; Han D; Huang Y; Dai Y; Wang Y; Liu M; Wang N; Yin T; Du W; He K; Zheng Y
Phytother Res; 2024 Feb; 38(2):713-726. PubMed ID: 38009260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
